Recent Developments: Daubert v. Merrell Dow Pharmaceuticals, Inc.: Reliability of Testimony Rather Than General Acceptance Provides the Standard for the Admissibility of Scientific Evidence in Federal Trials

Authors

Sandra G. Pike

Recommended Citation

Pike, Sandra G. (1993) "Recent Developments: Daubert v. Merrell Dow Pharmaceuticals, Inc.: Reliability of Testimony Rather Than General Acceptance Provides the Standard for the Admissibility of Scientific Evidence in Federal Trials," University of Baltimore Law Forum: Vol. 24: No. 1, Article 12.
Available at: https://scholarworks.law.ubalt.edu/lf/vol24/iss1/12